Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H16FN7 |
| Molecular Weight | 385.397 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](NC1=C2N=CNC2=NC=N1)C3=C(N=C4C=C(F)C=CC4=C3)C5=CC=CC=N5
InChI
InChIKey=KWRYMZHCQIOOEB-LBPRGKRZSA-N
InChI=1S/C21H16FN7/c1-12(28-21-19-20(25-10-24-19)26-11-27-21)15-8-13-5-6-14(22)9-17(13)29-18(15)16-4-2-3-7-23-16/h2-12H,1H3,(H2,24,25,26,27,28)/t12-/m0/s1
| Molecular Formula | C21H16FN7 |
| Molecular Weight | 385.397 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3130 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25469863 |
16.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:37:27 GMT 2025
by
admin
on
Mon Mar 31 23:37:27 GMT 2025
|
| Record UNII |
19DG7G1U5Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID501046373
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL3545048
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY | |||
|
100000175771
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY | |||
|
AMG 319
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY | |||
|
C95891
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY | |||
|
1608125-21-8
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY | |||
|
19DG7G1U5Q
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY | |||
|
68947304
Created by
admin on Mon Mar 31 23:37:27 GMT 2025 , Edited by admin on Mon Mar 31 23:37:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
>47-fold selectivity over other PI3Ks with potential immunomodulating and antineoplastic activities
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|